UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.27B
| $12.7M | ﹤0.01% |
381,741
+28,593
| +8% | +$964K |
|
2802
AvePoint
AVPT
$2.71B
| $12.7M | ﹤0.01% |
767,263
+665,528
| +654% | +$10.1M |
|
2803
CarGurus
CARG
$3.28B
| $12.6M | ﹤0.01% |
346,113
+172,190
| +99% | +$5.91M |
|
2804
iShares International Equity Factor ETF
INTF
$3.68B
| $12.6M | ﹤0.01% |
440,034
+2,506
| +0.6% | +$75K |
|
|
DNB
2805
DELISTED
Dun & Bradstreet
DNB
| $12.6M | ﹤0.01% |
1,013,560
+950,007
| +1,495% | +$11.4M |
|
2806
PUT
Under Armour
UAA
$2.73B
| $12.6M | ﹤0.01% |
1,525,000
+25,000
| +2% | +$228K |
|
2807
PUT
CVS Health
CVS
$123B
| $12.6M | ﹤0.01% |
281,100
+46,300
| +20% | +$2.6M |
|
2808
Capitol Federal Financial
CFFN
$1.11B
| $12.6M | ﹤0.01% |
2,134,941
+1,754,624
| +461% | +$11.2M |
|
2809
Corcept Therapeutics
CORT
$11.7B
| $12.6M | ﹤0.01% |
250,162
+71,966
| +40% | +$3.77M |
|
|
EH
2810
EHang Holdings
EH
$404M
| $12.6M | ﹤0.01% |
800,052
+756,415
| +1,733% | +$12.2M |
|
2811
Schwab International Small-Cap Equity ETF
SCHC
$5.59B
| $12.6M | ﹤0.01% |
366,910
+574
| +0.2% | +$20.9K |
|
2812
Franklin Electric
FELE
$4.83B
| $12.6M | ﹤0.01% |
129,002
+41,041
| +47% | +$4.27M |
|
2813
Dentsply Sirona
XRAY
$2.64B
| $12.6M | ﹤0.01% |
662,282
+391,411
| +145% | +$8.28M |
|
2814
Liberty Live Group Series C
LLYVK
$9.54B
| $12.6M | ﹤0.01% |
184,567
+68,300
| +59% | +$4.34M |
|
2815
PUT
Lennar Class A
LEN
$20.4B
| $12.5M | ﹤0.01% |
94,829
+619
| +0.7% | +$101K |
|
2816
First Financial Bankshares
FFIN
$4.97B
| $12.5M | ﹤0.01% |
347,013
+168,539
| +94% | +$6.54M |
|
2817
Idacorp
IDA
$8.15B
| $12.5M | ﹤0.01% |
114,304
+30,344
| +36% | +$3.34M |
|
2818
Axsome Therapeutics
AXSM
$10.8B
| $12.5M | ﹤0.01% |
147,347
+99,585
| +209% | +$9.16M |
|
|
HTLF
2819
DELISTED
Heartland Financial USA, Inc.
HTLF
| $12.5M | ﹤0.01% |
203,320
+44,744
| +28% | +$2.8M |
|
2820
Pacer Data & Infrastructure Real Estate ETF
SRVR
$379M
| $12.5M | ﹤0.01% |
415,540
+2,853
| +0.7% | +$89.3K |
|
2821
Veracyte
VCYT
$3.71B
| $12.4M | ﹤0.01% |
314,047
+133,275
| +74% | +$5.05M |
|
2822
Kforce
KFRC
$1.05B
| $12.4M | ﹤0.01% |
219,133
+111,765
| +104% | +$6.49M |
|
2823
Procept Biorobotics
PRCT
$1.14B
| $12.4M | ﹤0.01% |
154,113
+62,619
| +68% | +$5.35M |
|
2824
iShares MSCI Taiwan ETF
EWT
$10.6B
| $12.4M | ﹤0.01% |
239,634
+71,145
| +42% | +$3.86M |
|
2825
CALL
iShares Biotechnology ETF
IBB
$9.53B
| $12.4M | ﹤0.01% |
+93,800
| New | +$13.2M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.